Biologics CMC Leadership Group

The IQ Biologics CMC Leadership Group seeks to be a respected and credible means to advance biologics CMC development, be a recognized leader and collaborating partner in the biologics CMC industry/regulatory arena, and advance the IQ mission in the biologics space. The LG addresses a variety of modalities such as protein based drugs, vaccines, cell-based therapies, and gene therapy

The Group will collaborate with other IQ work-streams, collaborate with other industry organizations and global regulatory agencies, develop specific data-based work products where needed, and assist in efforts to bring consistency in global regulatory expectations for biologics.